Ketorolac versus morphine for severe pain

British Medical Journal

Volumn 321, Issue 7271, 2000, Pages 1236-1237

  Jelinek, G A ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC; MORPHINE;

DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL;

EID: 0034684440     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7271.1236     Document Type: Editorial

References (10)

1. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
2. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study
3. Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: Double blind randomised controlled trial
4. The identification of costs associated with emergency department attendances
5. Increased health care costs associated with ED overcrowding
6. Overcrowding in the nation's emergency departments: Complex causes and disturbing effects
7. ED overcrowding in Taiwan: Facts and strategies
8. Financial incentives to change emergency service performance